Unison Laboratories

What Unison Laboratories does

Unison Laboratories is a Thailand-based pharmaceutical manufacturer founded in 1956 and headquartered in Chachoengsao, operating as a wholly-owned subsidiary of B.GRIMM Pharma following the 2022 acquisition. The company manufactures over 800 registered pharmaceutical products — including generic medicines, dietary supplements, and cosmetic health items — under GMP, ISO, and Halal certifications, with products meeting standards set by Thailand's Food and Drug Administration (FDA) and the Ministry of Public Health.

Unison operates a single manufacturing site focused on high-volume generic production and supplies government hospitals, private hospitals, state enterprises, clinics, and pharmacies in Thailand, with international reach via its sister company Medline, which distributes to 5,000+ domestic locations and partner markets in over 17 countries. Within the B.GRIMM Pharma group, Unison sits alongside Medline (sales and distribution), F.C.P. (consumer health and contract manufacturing under brands such as Nutrimaster, Concept, EXXE, and Clearasoft), and All Research (bioequivalence and clinical research under GCP/GLP standards), creating a vertically integrated healthcare platform spanning R&D, manufacturing, distribution, and consumer health. Pricing is not publicly disclosed, and the company monetizes through B2B supply contracts with public and private healthcare providers rather than direct-to-consumer channels.

The company does not disclose revenue, ARR, headcount trends, or detailed financial metrics, and there is no public information on leadership team composition, AI/ML capabilities, patents, or independent funding activity, as Unison is wholly owned by B.GRIMM Pharma, itself part of the diversified B.Grimm Group dating to 1878.

Name

Unison Laboratories

Legal name

Unison Laboratories

Website

https://unisonlab.com

Company type

Private

Founded year

1956

Operating status

Operating

Headcount range

101–250 employees

Short description

Unison Laboratories is a Thailand-based pharmaceutical manufacturer (founded 1956, Chachoengsao) producing 800+ registered generic medicines under GMP/ISO/Halal certification. A wholly-owned subsidiary of B.GRIMM Pharma since 2022, it supplies government hospitals, private healthcare, and international partners.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Medical supplies
• Healthcare distribution
• Dietary supplements

Headquarters

HQ city

Chachoengsao

HQ country

Thailand

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Distribution channels4 records

Marketing channels1 record

Core offering

Unison Laboratories manufactures high-quality generic medicines, dietary supplements, and medical supplies under World-Class pharmaceutical manufacturing standards. Operating from Chachoengsao, Thailand, the company produces over 800 registered pharmaceutical products that meet stringent standards set by Thailand's FDA and the Ministry of Public Health. Since its 2022 acquisition by B.GRIMM Pharma, Unison supplies these products to government hospitals, private hospitals, state enterprises, clinics, and pharmacies domestically and internationally.

Product overview

Unison Laboratories operates as part of B.GRIMM Pharma, which is Thailand's leading developer and provider of pharmaceutical and healthcare solutions. The company offers a diversified portfolio spanning pharmaceutical manufacturing (Unison), sales and distribution (Medline), consumer health products and contract manufacturing (F.C.P.), and clinical R&D services (All Research). Unison manufactures over 800 registered pharmaceutical products including generic medicines, dietary supplements, and cosmetic health products. The group operates across the entire value chain from research and development through manufacturing, marketing, sales, and distribution.

Differentiator

Problem solved

Functional benefit

Products and services

• Unison Pharmaceuticals Manufacturing of high-quality generic medicines, dietary supplements, and medical supplies under World-Class pharmaceutical manufacturing standards. The portfolio includes over 800 registered pharmaceutical products serving government and private hospitals, state enterprises, clinics, and pharmacies domestically and internationally, with products meeting Thailand FDA and Ministry of Public Health standards.

Named customers5 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• B.GRIMM PharmacoreStrategic or Co-development PartnerUnison was acquired by B.GRIMM Pharma in 2022 along with Medline, F.C.P., and All Research as part of strengthening B.Grimm's healthcare business. Unison operates under B.GRIMM Pharma, manufacturing high-quality medicines and medical supplies with world-class standards and operational excellence.

Recent moves4 records

Expansion highlights5 records

Regional players

• Hovid Berhad: Malaysia-based pharmaceutical manufacturer producing generic finished dosage forms and consumer health products for domestic and export markets. Comparable to Unison in generic pharmaceutical manufacturing and ASEAN regional reach.
• Y.S.P. Industries: Malaysia-based pharmaceutical manufacturer with a broad generic portfolio serving domestic and ASEAN markets. Comparable to Unison in generic manufacturing, regulatory positioning, and regional Southeast Asian distribution, though headquartered in a different country.

Direct peers

• Greater Pharma Co., Ltd. Thai pharmaceutical manufacturer producing generic finished dosage forms for domestic distribution. Comparable to Unison as a Thailand-based generic FDF manufacturer serving similar healthcare provider customers.
• Government Pharmaceutical Organization (GPO): Thailand's state-owned pharmaceutical manufacturer producing generic medicines and supplies for the public healthcare system. GPO directly competes with Unison in the same Thai generic manufacturing market, supplying government hospitals and competing for similar institutional contracts.
• Mega Lifesciences: Thailand-headquartered pharmaceutical company manufacturing and distributing generic medicines, supplements, and OTC products across Southeast Asia and emerging markets. Comparable to Unison in scale, Thai origin, generic focus, and regional export orientation.
• Berlin Pharmaceutical Industry Co., Ltd. Established Thai pharmaceutical manufacturer of generic medicines and medical supplies serving government and private healthcare channels. Comparable to Unison in domestic Thai manufacturing, generic portfolio, and institutional customer base.
• Olic (Thailand) Co., Ltd. Thai manufacturer of pharmaceutical and nutraceutical products with a broad generic portfolio serving domestic and export markets. Comparable to Unison as a Thailand-based generic pharmaceutical manufacturer serving institutional and consumer healthcare channels.
• T.O. Chemical Pharma: Thai pharmaceutical manufacturer producing generic drugs and consumer health products for domestic and international markets. Comparable to Unison as a Thailand-based generic pharmaceutical manufacturer with overlapping therapeutic categories and customer channels.

Broad incumbents

• PT Kalbe Farma: Indonesia's largest pharmaceutical company with a broad portfolio spanning generics, consumer health, and distribution across the region. Comparable to Unison in generic pharmaceutical manufacturing and ASEAN market focus, though Kalbe operates at substantially larger scale.

Emerging players

• Dexa Medica: Indonesia-based pharmaceutical company with a strong generic and consumer health portfolio across Southeast Asia. Comparable to Unison as a regional Southeast Asian generic manufacturer with international distribution, though operating from a different home market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/HR-Unison-396370980757892
• LinkedInlinkedin.com/company/unison-laboratories

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unison Laboratories